147
Views
0
CrossRef citations to date
0
Altmetric
Review Article

A systematic review of prevalence of comorbid obsessive-compulsive disorders and substance use disorders in clinical settings, 1990-2021

ORCID Icon & ORCID Icon
Pages 180-185 | Received 27 Feb 2022, Accepted 10 Nov 2022, Published online: 22 Nov 2022
 

ABSTRACT

Background and Objective

Obsessive-compulsive disorder (OCD) is a chronic debilitating illness. Individuals experience severe impairment in their functioning. It is associated with multiple psychiatric comorbidities. OCD is associated with increased stress states and negative affect, to relive these states, individuals can use substances to alleviate their distress. OCD and substance use disorders share similar brain pathways.

Methods

The aim of this review was to systematically review and summarize the evidence regarding the prevalence of obsessive-compulsive disorder and substance use disorders in a clinical sample. A systematic review was conducted using MEDLINE, PsycINFO, EMBASE and CINAHL to identify relevant peer-reviewed journals published between January 1990 and August 2021.

Results

Six studies were identified with a total sample size of 2,559 participants. OCD has a high comorbidity with substance use, alcohol use disorder was the highest reported comorbidity, the onset of OCD preceded that of substance use. The number of studies that have reported on the relationship between specific substance use and OCD is insufficient.

Conclusion and Scientific Significance

Despite the high comorbidity of SUDS and OCD, insufficient studies have been conducted. Clinicians need to explore substance use histories amongst individuals with OCD attending their clinics.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.